Sex differences exist in chronic pain pathologies, and gonadal estradiol (E2) alters the pain sensation. The nocisensor transient receptor potential vanilloid 1 (TRPV1) receptor plays a critical role in triggering pain. Here we examined the impact of E2 on the function of TRPV1 receptor in mice sensory neurons in vitro and in vivo. Both mechano-and thermonociceptive thresholds of the plantar surface of the paw of female mice were significantly lower in proestrus compared with the estrus phase. These thresholds were higher in ovariectomized (OVX) mice and significantly lower in sham-operated mice in proestrus compared with the sham-operated mice in estrus phase. This difference was absent in TRPV1 receptor-deficient mice. Furthermore, E2 potentiated the TRPV1 receptor activation-induced mechanical hyperalgesia in OVX mice. Long pretreatment (14 hours) with E2 induced a significant increase in TRPV1 receptor messenger RNA expression and abolished the capsaicin-induced TRPV1 receptor desensitization in primary sensory neurons. The short E2 incubation (10 minutes) also prevented the desensitization, which reverted after coadministration of E2 and the tropomyosin-related kinase A (TrkA) receptor inhibitor. Our study provides in vivo and in vitro evidence for E2-induced TRPV1 receptor upregulation and sensitization mediated by TrkAR via E2-induced genomic and nongenomic mechanisms. The sensitization and upregulation of TRPV1 receptor by E2 in sensory neurons may explain the greater pain sensitivity in female mice. (Endocrinology 158: 3249-3258, 2017) 
Sex differences exist in chronic pain pathologies, and gonadal estradiol (E2) alters the pain sensation. The nocisensor transient receptor potential vanilloid 1 (TRPV1) receptor plays a critical role in triggering pain. Here we examined the impact of E2 on the function of TRPV1 receptor in mice sensory neurons in vitro and in vivo. Both mechano-and thermonociceptive thresholds of the plantar surface of the paw of female mice were significantly lower in proestrus compared with the estrus phase. These thresholds were higher in ovariectomized (OVX) mice and significantly lower in sham-operated mice in proestrus compared with the sham-operated mice in estrus phase. This difference was absent in TRPV1 receptor-deficient mice. Furthermore, E2 potentiated the TRPV1 receptor activation-induced mechanical hyperalgesia in OVX mice. Long pretreatment (14 hours) with E2 induced a significant increase in TRPV1 receptor messenger RNA expression and abolished the capsaicin-induced TRPV1 receptor desensitization in primary sensory neurons. The short E2 incubation (10 minutes) also prevented the desensitization, which reverted after coadministration of E2 and the tropomyosin-related kinase A (TrkA) receptor inhibitor. Our study provides in vivo and in vitro evidence for E2-induced TRPV1 receptor upregulation and sensitization mediated by TrkAR via E2-induced genomic and nongenomic mechanisms. The sensitization and upregulation of TRPV1 receptor by E2 in sensory neurons may explain the greater pain sensitivity in female mice. (Endocrinology 158: 3249-3258, 2017) P ain is modulated by gonadal steroids (1) , and wellestablished sex differences exist in chronic pain conditions (2) . A great body of clinical evidence has demonstrated the higher sensitivity of women to chronic pain (3) (4) (5) (6) (7) (8) . Furthermore, experimental data revealed that pain sensitivity is higher in women and that it is affected by the stage of estrous cycle in rodents (9) . Estrogens exert both pro-and antinociceptive effects through different neuronal and nonneuronal mechanisms via slow genomic actions (10) . Estrogen receptors (ERa and ERb) are expressed in primary sensory neurons especially in smalland medium-diameter nociceptors (11) . 17b-estradiol (E2) acts on ERa in sensory neurons to modulate pain transmission (12) . The membrane G protein-coupled estrogen receptor (GPER1) in primary sensory neurons (13, 14) and in spinal somatosensory neurons mediates rapid, nongenomic estrogen pain-modulating intracellular signaling (15) .
The transient receptor potential vanilloid 1 (TRPV1) receptor is a nonselective cation channel predominantly expressed on capsaicin-sensitive peptidergic polymodal nociceptors. In addition to the classical exogenous vanilloid agonists capsaicin and resiniferatoxin (RTX), the TRPV1 receptor is gated by noxious chemicals, heat (.43°C), protons (pH ,6.0) (16) (17) (18) (19) (20) , arachidonic acid, and other fatty acid metabolites (21) (22) (23) (24) (25) . Importantly, the TRPV1 receptor is sensitized by several inflammatory mediators and by nerve growth factor (NGF), a tropomyosin-related kinase A receptor (TrkA) ligand (26) .
Interactions between ERs and TRPV1 receptors have been shown in primary sensory neurons, indicating a potential mechanism for the explanation of sex differences in pain. E2 directly increases nociceptor excitability, reduces action potential thresholds, and facilitates TRPV1 activation in primary sensory neurons (27, 28) . TRPV1 sensitization has been shown by other factors, such as NGF via TrkA signaling (26) . Clinical studies demonstrated that women feel capsaicin-evoked pain more intensely than men (29) . Furthermore, the number of TRPV1 receptors significantly decreased in ERa and ERb knockout mice (30) , suggesting that E2 may regulate the expression of TRPV1 via ERs. Although these data suggest that E2 might be an important regulator of TRPV1-mediated nociception, little attention has been given to the sex differences and to the role of E2 in TRPV1 receptor-related nociceptive actions. There are no data in mouse models, especially with TRPV1 knockout (TRPV1 2/2 ) mice. Therefore, we examined the sex differences and effects of endogenous E2 on mechano-and thermonociceptive responses in TRPV1 2/2 mice in comparison with their wild types as well as the effects of E2 on the TRPV1 channel and related signaling in vivo and in vitro.
Materials and Methods

Animals and treatments
Eight-week-old adult female and male C57BL/6J wild-type (WT) and TRPV1 knockout (TRPV1 2/2 ) mice (Jackson Laboratories, Bar Harbor, ME) were used for the experiment. The animals were kept in the Laboratory Animal House of the Department of Pharmacology and Pharmacotherapy, University of Pécs, under a 12-hour light/12-hour dark cycle at 24 to 25°C and had access to food and water ad libitum.
In one group, eight female mice were bilaterally ovariectomized (OVX) under avertin anesthesia (1.9% tribromoethanol and 1.2% amyl-hydrate in saline; 0.1 mL/10 g body weight). Mice were treated with E2 (33 ng/g subcutaneously in 0. 
Measurement of the mechano-and thermonociceptive thresholds
The mechanonociceptive threshold of the plantar surface of the paw was determined by dynamic plantar aesthesiometry (Ugo Basile, Comerio, Italy). After a 45-minute habituation period, the withdrawal thresholds for mechanical stimulation were recorded in grams (31) .
The thermonociceptive threshold of the paw was measured on an increasing temperature hot plate (IITC Life Sciences, Woodland Hills, CA) by the temperature when the mice showed nocifensive reactions (lifting, licking, shaking). The cutoff value was 53°C (32) .
These thresholds of WT and TRPV1 2/2 male and female mice (n = 8 in each group) were investigated for 14 consecutive days at the same time each morning. Then the estrous cycle phase was determined by vaginal smear as described previously (33) .
Evaluation of estrus cycle
Vaginal smears were taken every morning, 1 hour before the nociceptive testing. Vaginal material was stained by 0.1% aqueous solution of methylene blue and examined under a microscope to evaluate the stage of estrus cycle (33) . The threshold values were compared in the estrous and proestrous stages.
Investigation of inflammatory hyperalgesia induced by the TRPV1 agonist RTX
Acute neurogenic inflammation and consequent hyperalgesia (drop of the mechano-and thermonociceptive thresholds) were induced in the right hindpaw by intraplantar administration of the TRPV1 agonist RTX (0.01 mg/mL, 20 mL) or saline control (34) . We are unable to measure reliably the heat and mechanonociceptive threshold-decreasing effect of the classical TRPV1 receptor agonist capsaicin, most probably due to the very pronounced capsaicin-induced nocifensive reaction. RTX does not exert as intensive acute pain reaction as capsaicin and thus is more suitable for the examination of the hyperalgesic responses (35) . The thermonociceptive thresholds were determined before and 10 minutes, 30 minutes, 1 hour, and 2 hours after the stimulation. In a separate group, E2 treatment (33 ng/g, subcutaneously) was performed before RTX or saline administration. In our previous studies, 33 ng/g E2 rapidly induced cAMP response element binding protein phosphorylation (within 15 minutes) in the central nervous system (36) . Therefore, measurements were performed 10 minutes, 30 minutes, 1 hour, and 2 hours after an intraplantar RTX administration.
Primary cultures of primary sensory neurons of the dorsal root ganglia
Cultures of primary sensory neurons were made from the dorsal root ganglia (DRG) of 2-to 4-day-old C57BL/6J WT mouse pups. The ganglia were cut and placed into ice-cold phosphate-buffered saline (PBS) and incubated for 35 minutes at 37°C in PBS containing collagenase (Type XI, 1 mg/mL) and then in PBS with deoxyribonuclease I (1000 U/mL) for 8 minutes. The ganglia were washed with PBS and dissociated by trituration. Cell cultures were plated on poly-D-lysin-coated glass coverslips and grown in a nutrient-supplemented medium that contained 180 mL Dulbecco's modified Eagle medium, 20 mL horse serum, 20 mL bovine albumin, 2 mL insulin-transferrin-selenium-S, 3.2 mL putrescin dihydrocloride (100 mg/mL), and 20 mL triiodothyronine [0.2 mg/mL, 1.24 mL progesterone (0.5 mg/mL), 100 mL penicillin, 100 mL streptomycin]. Cultures were maintained at 37°C in a humidified atmosphere with 5% CO 2 , and NGF (200 ng/mL) was added every second day as described elsewhere (37) .
Calcium imaging of TRPV1 activation in primary cultures of DRG neurons
Cell cultures (1 to 2 days old) were stained, and cell lines were loaded for 30 minutes at 37°C in a solution containing (in mM): NaCl, 122; KCl, 3. indicator dye (fura-2-AM; Molecular Probes, Eugene, OR). Dye loading was followed by at least 5 minutes of washing in extracellular solution (ECS) containing (in mM): NaCl, 160; KCl, 2.5; CaCl 2 , 1; MgCl 2 , 2; HEPES, 10; glucose, 10; (pH 7.3). ECS was gravity fed to the cells using a triple outlet tube. Test solutions arrived to the outlet via separate tubes using a fast step perfusion system (VC-77SP; Warner Instrument Corp., Hamden, CT, Harvard Apparatus GmbH, March, Germany). Calcium transients of DRG neurons to capsaicin were examined with microfluorometry as described elsewhere in detail (38) . Briefly, fluorescence images were taken with an Olympus LUMPLAN FI/ x20 0.5 W water immersion objective and a digital camera (SensiCam CCD; PCO AG, Kelheim, Germany) that was connected to a computer. Up to 12 dye-loaded cells were selected in each plate to monitor their fluorescence individually. Cells were illuminated alternately with 340 and 380 nm light generated by a monochromator (Polychrome II; Till Photonics, Gräfelfing, Germany) under the control of Axon Imaging Workbench 2.1 (Axon Instruments, Union City, CA). The emitted light was measured .510 nm, the R = F340/F380 was monitored (rate 1 Hz) continuously, and a few sample images were also recorded. The R values were generated by AIW 2.1 software and then processed by the Origin software version 7.0 (Originlab Corp., Northampton, MA). Neurons were incubated with 200 pM or 1 nM E2 overnight (14 hours) at 37°C in a humidified atmosphere with 5% CO 2 or were untreated controls. In in vitro examinations, we used the TRPV1 receptor selective capsaicin (RTX is not suited for in vitro application because of the difficulty of washout). Five repeated stimulations of 330 nM capsaicin for 10 seconds were performed during a 50-minute period, and then capsaicin stimulus was repeated after a 10-minute washout period. A short (10-minute) E2 treatment or E2 and AG879 coadministration was performed after the third capsaicin.
Quantitative real-time polymerase chain reaction
The total RNA was extracted from treated and untreated mouse DRG cells with TRI Reagent (Molecular Research Centre Inc., Cincinatti, OH) and with Direct-Zol RNA isolation kit following the manufacturer's instructions. RNA samples were treated with deoxyribonuclease I (Zymo Research, Irvine, CA) and quantified by spectrophotometer (NanoDrop ND-1000; NanoDrop Technologies Inc., Wilmington, DE). Purified RNA (1 mg) was reverse transcribed into complementary DNA (cDNA) using a Maxima First Strand cDNA Synthesis Kit for reverse transcription real-time quantitative polymerase chain reaction (qPCR) (Thermo Fisher Scientific, Waltham, MA). Real-time qPCR was conducted with a Stratagene Mx3000P QPCR System (Agilent Technologies, Santa Clara, CA) using glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a reference gene. Each reaction contained 20 ng cDNA, 1x Luminaris HiGreen Low ROX qPCR Master Mix (Thermo Fisher Scientific), and 0.3 mM from each primer. Real-time qPCR cycle conditions were as follows: 95°C for 10 minutes, followed by 40 cycles of 95°C for 30 seconds, 60°C for 30 seconds, then 72°C for 1 minute. To amplify the target loci, the following primers were used in the current study: Gapdh (sense): 5ʹ-TGCACCACCAACTGCT-TAGC-3ʹ and (antisense): 5ʹ-GGCATGGACTGTGGTCATGAG-3ʹ; Trpv1 (sense): 5 0 -ATGCTGGGTCATTTCTCCCC-3 0 and (antisense): 5 0 -AGCGTACCCCCACTTTCTCT-3 0 ; G protein-coupled estrogen receptor 1 (Gper1) (sense): 5ʹ-CACCTGGATGAGCT-TCGACA-3ʹ and (antisense): 5ʹ-TGCACCGCTGTGAAGGG-3ʹ; estrogen receptor 1 alpha (Esr1) (sense): 5ʹ-AGCTGTCTCCTT-TCCTGCAC-3ʹ and (antisense): 5ʹ-TTAGACCTGTAGAAGGC-GGGA-3ʹ; estrogen receptor beta (Esr2) (sense): 5 0 -TGTTAC-TAGTCCAAGCGCCAA-3 0 and (antisense): 5 0 -ACCAGA-CACCGTAATGATACCC. All real-time polymerase chain reaction experiments were carried out in triplicate, and the mean value was used for the determination of messenger RNA (mRNA) expression levels. Measurements included a dissociation curve analysis to verify the amplification specificity. The relative gene expression ratios were calculated according to the comparative DDCt method using samples of untreated animals as calibrator. When calculating gene expression ratios, primer efficiencies were taken into account (38) . Neurons were incubated with 200 pM or 1 nM E2 overnight at 37°C in a humidified atmosphere with 5% CO 2 or were untreated controls.
Drugs and chemicals
Capsaicin (Sigma, Budapest, Hungary) was dissolved in dimethyl sulfoxide to obtain 10 mM stock solution. Further dilutions were made with ECS to reach final concentrations of 330 nM. Dulbecco's modified Eagle medium, horse serum, fetal bovine albumin, and newborn calf serum were purchased from Gibco (Grand Island, NY). Collagenase, deoxyribonuclease I, poly-D-lysine, NGF, RTX, AG879, and E2 were purchased from Sigma-Aldrich.
Statistical analysis
GraphPad Prism 5.0 (GraphPad, La Jolla, CA) was used for statistical analyses. For evaluating gene expression, analysis was processed by one-way analysis of variance (ANOVA) followed by Dunnett's multiple comparison. Calcium imaging and qPCR data are expressed as means 6 standard error of the mean (SEM) of three independent experiments. Statistical analysis was performed by one-way ANOVA with Bonferroni post hoc test.
Results of the in vivo investigations were evaluated with oneway ANOVA with Bonferroni multiple comparison post hoc tests and are shown as means 6 SEM (n = 8 per group). Differences between groups were assessed by two-way ANOVA with Bonferroni multiple comparison post hoc tests. Significance levels were P # 0.05, P # 0.01, and P # 0.001.
Results
Sex hormone-dependent differences in mechanoand thermonociceptive thresholds in mice
To evaluate the sex difference in pain sensation, the mechanonociceptive and thermonociceptive thresholds were detected in both sexes.
Mechano-and thermonociceptive thresholds of the plantar surface of the paw of female C57BL/6J WT mice in proestrous were significantly lower than those of estrous female mice and male mice [ Fig. 1(a) thermonociceptive values were 48.11 6 0.38, 47.921 6 0.45, and 48.52 6 0.39 in proestrous female, estrous female, and male mice, respectively.
TRPV1 activation-induced mechanical hyperalgesia is potentiated by E2
To examine the effect of E2 on TRPV1 receptor activation, TRPV1 receptor agonist RTX was applied to E2-primed OVX mice. Mechanical hyperalgesia developed in response to intraplantar administration of the TRPV1 receptor agonist RTX (0.01 mg/mL) both in OVX and E2-primed OVX mice. This reached a maximum of 52.8% after 10 minutes, which gradually decreased during the 120-minute examination period. E2 treatment increased the nociceptive response from the 30 minutes as shown by shifting down the hyperalgesia curve, suggesting an E2-induced TRPV1 sensitization. Intraplantar administration of saline did not cause mechanical hyperalgesia (Fig. 2) .
ERa, ERb, GPER1, and TRPV1 mRNA are expressed in cultured primary sensory neurons
To clarify whether the primary sensory neurons express ERs, we examined the presence of ERa, ERb, and GPER1 mRNAs in DRG cultures obtained from WT mice. All three receptor mRNSs were detected in these cells (n = 3 independent cell cultures) (Fig. 3) . Overnight incubation with 100 pM, but not with 1 nM concentration of E2, caused a significant, 15-fold increase in TRPV1 mRNA expression compared with the untreated controls. In contrast, short (10-minute) treatments did not remarkably alter TRPV1 expression (Fig. 4) .
E2 enhances capsaicin-induced TRPV1 receptor activation in cultured primary sensory neurons
To examine the effect of E2 on TRPV1 receptor activation, ratiometric calcium imaging was applied on capsaicin-treated DRG neurons.
The TRPV1 agonist capsaicin (330 nM) alone caused a robust and transient Ca 2+ influx into 64 neurons out of 120 neurons (53%; mean of R value of the first capsaicin, 0.59 6 0.06) followed by desensitization (R = 0.31 6 0.05 after the second capsaicin application; n = 64) [ Fig. 5(a) and 5(b) ]. The vehicle control alone did not cause Ca 2+ influx. Overnight pretreatment of DRG neurons with 100 pM E2 abolished the capsaicininduced TRPV1 receptor desensitization [ Fig. 5(c) ].
In the following experiments, five repeated treatments of capsaicin on the same cultured sensory neurons were performed for 50 minutes. First, application of 330 nM capsaicin for 10 seconds induced transient Ca 2+ accumulation in the cytosol as detected by the magnitude of the fluorescence response R = 0.55 6 0.06. Capsaicin stimulus was repeated after a 10-minute washout period. The second and third responses were gradually smaller due to TRPV1 desensitization (R = 0.33 6 0.06 and R = 0.27 6 0.06, respectively). A short (10-minute) E2 
Discussion
Major findings
We present here data that E2 sensitizes the TRPV1 receptor via direct and indirect mechanisms through the TrkA pathway and upregulates its expression. These findings explain the hormonal cycle-dependent pain sensitivity alterations.
It is well established that TRPV1 has a key role in pain signaling (35, 39, 40) , and some data have suggested interactions between E2 and TRPV1. Data have mostly showed increased TRPV1 activation after E2 administration, but this crosstalk was not investigated by a comprehensive experimental approach, and the mechanism was not clear.
Electrophysiological data demonstrated that E2 facilitates TRPV1-transmitted ion currents in rat sensory neurons (41) . TRPV1-evoked nocifensive responses were more pronounced in female rats via E2-mediated processes (42) . These are supported by the present results showing significantly reduced RTX-evoked hyperalgesia in OVX mice, which is reversed by exogenous E2 administration. In agreement with these experimental findings, clinical data also described that women feel capsaicinevoked pain more intensively than men, presumably by differential modulation of the TRPV1 receptor by sex steroids (29) . E2 application increased nociceptor excitability, reduced action potential thresholds, and facilitated TRPV1 activation in sensory neurons (27, 28) . In addition to the sensitivity, the expression of TRPV1 was significantly increased by overnight incubation of primary sensory neuronal cultures with E2, similarly to the endometrial cells (43) . Our findings demonstrated that 1-day 100 pM E2 significantly increased the TRPV1 mRNA level and that primary sensory neurons express estrogen receptors (ERs), such as ERa, ERb, and GPER1. Although, the type of ERs involved in this mechanism is not specified, it is likely that E2 alters the expression of TRPV1 in primary sensory neurons via ERs. However, 1-day treatment with 1 nM E2 is considered a pharmacological treatment regimen. There was no response to a 1 nM dose of E2 in our experiment. Importantly, several studies have demonstrated that the pharmacological dosage/concentration of E2 downregulates ERs in neurons (44, 45) . One can assume that downregulation of ERs may contribute to the diminished action of E2 on TRPV1 transcription, leading to the observed inverse concentration-dependent action. Glia cells in the cultures might mediate some of the actions of E2, but only a limited number of studies deal with the satellite cells and estrogen receptors. ERa, but not ERb, was observed in satellite glial cells of the trigeminal ganglia (46) . These in vitro results are supported by the E2-induced increased temporomandibular joint pain and TRPV1 upregulation in the synovial membrane, explaining the dominant representation of this disease in female mice (47) . Similarly, exogenous E2 upregulated TRPV1 expression in sensory neurons of OVX rats, and the lack of E2 effect in ERaKO and ERbKO mice resulted in TRPV1 downregulation (30) .
Potential mechanism of action
In agreement with previous studies (13) (14) (15) , our results demonstrated the expression of ERa, ERb, and GPER1 in primary sensory neurons. Overnight E2 treatment abolished the capsaicin-induced TRPV1 desensitization, and sensitization developed within a short, 10-minute period. In our studies, GAPDH was proven to be a stable and reliable reference gene in primary sensory neurons, and it is used as a standard housekeeping gene for qPCR technique (48, 49) . Several reports have stated that E2 treatment had no effect on GAPDH expression (50, 51) .
Therefore, the effect of E2 on TRPV1 is likely to involve the classical genomic and the rapid nonclassical GPER1-mediated action via PKCs. The GPER1-mediated fast sensitization is supported by our result demonstrating TRPV1 activation-induced mechanical hyperalgesia increase 30 minutes after E2 administration and by recent data showing mechanical hyperalgesia 20 minutes after exogenous E2 in OVX rats (52) . It is also established that E2 level regulates GPER1 expression; it is downregulated in sensory neurons after OVX in rats and recovers by E2 replacement (15) .
E2-evoked GPER1 activation results in rapid intracellular cAMP and Ca 2+ increase (within minutes and even seconds)
in sensory neurons (53) (54) (55) (56) (57) (58) . Intracellular Ca 2+ elevation stimulates protein kinase C« (PKC«) and evokes pain sensitization, supporting GPER1-induced E2 actions (59, 60) . The target of PKC« phosphorylation is serine 800 (S800) at the C-terminus of TRPV1. Goswami et al. (61) suggest the C-terminus of TRPV1 to be a signaling intermediate downstream of estrogen and PKC«, regulating microtubule stability and microtubule-dependent pain sensitization.
E2-induced nociceptor excitability and TRPV1 sensitization in sensory neurons (27, 28) are similar to the effects of NGF acting through the TrkA receptor. This activates a signaling pathway in which phosphoinositide-3 kinase plays a crucial early role, with Src kinase as the downstream element phosphorylating the TRPV1. Phosphorylation at a single tyrosine residue explains most of the rapid effects of NGF on TRPV1. A major effect of NGF is causing a translocation of TRPV1 to the cell surface membrane. NGF treatment for 10 minutes induced a 1.6-fold increase in membrane TRPV1 expression on HEK293 cells transfected with both TrkA and TRPV1 (26) . Our result that the TrkA inhibitor abolished the E2-induced TRPV1 sensitization in sensory neuronal cultures provided evidence that a NGF-like mechanism can be suggested for E2. This is likely to explain the higher pain sensitivity in female mice and may be related to the molecular mechanism of E2-induced enhanced TRPV1 activation in sensory neurons.
This mechanism cannot also be proposed for the nonneural cells the central nervous system. In primary cultured synoviocytes, TRPV1 is upregulated by E2 and NGF, and NGF antibodies fully block E2-induced TRPV1 increase (62) . The hippocampus plays an important role in sexbased differences of pain perception. Hippocampal NGF, as well as synovial NGF and TRPV1, were upregulated in the case of temporomandibular inflammation in the rat, which was further potentiated by E2. Blocking this central NGF and its TrkA pathway partially reversed the allodynia of the inflamed temporomandibular joint (63) . Therefore, in addition to a direct action, E2-evoked TRPV1 sensitization might involve a NGF-mediated mechanism. There is clear evidence that estrogen increases the excitability of rat temporomandibular joint afferents and augments the inflammation-induced sensitization of the sensory neurons (27) . The present findings support this hypothesis and specify the role of TRPV1 receptors in this mechanism. Therefore, we can hypothesize that blocking estrogen's effect on the sensory nerves by selective estrogen receptor modulators might have analgesic potentials in different chronic pain conditions in women.
Clinical significance
Sex differences in chronic pain pathologies are well established (2) . Most data describe that women are overrepresented in chronic pain conditions compared with men until menopause (4-7, 64, 65) . In general, women have a higher prevalence of musculoskeletal degenerative diseases accompanied by severe pain, such as discopathies and low back pain. However, pain was shown to further increase in the postmenopausal period with lower estrogen levels (66, 67) , which contradicts the E2-induced pain sensitization concept. This finding is easily explained by the lack of an E2-evoked protective effect on the bones and the musculosceletal system, and the postmenopausal greater degenerative process obviously causes more intensive pain. Because extensive clinical studies with a variety of multiple complicating factors (psychological, geographical, genetic and epigenetic background, education, physical exercise, etc.) are not appropriate to draw conclusions for E2-induced pain modulation (68, 69) , systematic experimental investigations are needed to reveal the mechanisms.
In summary, this comprehensive approach provides in vivo and in vitro evidence for E2-induced TRPV1 receptor upregulation and sensitization both via the classical genomic and the rapid, nongenomic estrogen action mediated by TrkA. E2-induced TRPV1 sensitization and upregulation in sensory neurons can explain greater pain sensitivity in women.
